Matthew Scholz has been told many times that his idea for reprogramming the body’s immune cells to create drugs was impossible. Maybe dangerous. Maybe just dumb.
Scholz, a computer scientist with no formal biology training, could easily have been written off as a quixotic dreamer until this spring, when he got his breakout moment. The foundation started by Peter Thiel, the billionaire co-founder of PayPal, decided that Scholz’s startup, Immusoft, just might be onto something, granting it close to $400,000.
To read the full, original article click on this link: A Computer Guy’s Dream, Immusoft, Turns Cells Into Drug Factories | Xconomy
